30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Marc Becker

Track

Insider profile

Currently holds a position at Concert Pharmaceuticals Inc

Positions

Position Company Period
Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer Concert Pharmaceuticals Inc Nov. 27, 2019 -
Chief Financial Officer, Principal Financial Officer Concert Pharmaceuticals Inc Jan. 4, 2018 - Nov. 27, 2019
Chief Financial Officer CRISPR Therapeutics AG Feb. 1, 2016 - Sept. 30, 2017
Marc Becker's trades of Concert Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-16 2023-02-15
PlS Planned sale
9,323 +49.4%
37.82
US$3,692,381 		9,323 +49.4% 37.82 US$3,692,381
2023-01-31 2023-01-30
PlS Planned sale
3,258 +38.0%
207.86
US$3,095,595 		3,258 +38.0% 207.86 US$3,095,595
2023-01-09 2023-01-06
PlS Planned sale
43,821 +14.2%
311.91
US$2,487,934 		43,821 +14.2% 311.91 US$2,487,934
2022-02-16 2022-02-14
PlS Planned sale
3,762 -2.6%
3.08
US$11,587 		3,762 -2.6% 3.08 US$11,587
2022-01-07 2022-01-05
PlS Planned sale
2,894 -4.5%
3.20
US$9,261 		2,894 -4.5% 3.20 US$9,261
2021-02-17 2021-02-16
PlS Planned sale
3,763 -5.0%
7.32
US$27,545 		3,763 -5.0% 7.32 US$27,545
2020-08-19 2020-08-17
PlS Planned sale
2,875 -5.1%
10.24
US$29,440 		2,875 -5.1% 10.24 US$29,440